B-ALL
Clinical trials for B-ALL explained in plain language.
Never miss a new study
Get alerted when new B-ALL trials appear
Sign up with your email to follow new studies for B-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tackle tough leukemia
Disease control Not yet recruitingThis study looks at whether giving two drugs together—inotuzumab and blinatumomab—is safe and works well for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). The trial includes people who are older or cannot handle standard strong chemotherapy. The goal is…
Matched conditions: B-ALL
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 23:38 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-phase trial tests a new treatment called TSLPR-CART for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to recognize and attack cancer ce…
Matched conditions: B-ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC